Trial · NCT07583888
VABu Conditioning in Elderly AML HSCT
NCT07583888, Phase 2, Phase 3, Recruiting, The First Affiliated Hospital of Soochow University
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. VABu Conditioning in Elderly AML HSCT. Trials, record NCT07583888. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07583888
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- VABu Conditioning in Elderly AML HSCT
- NCT number
- NCT07583888
- Status
- Recruiting
- Phases
- Phase 2, Phase 3
- Enrollment
- 20 participants, estimated
- Lead sponsor
- The First Affiliated Hospital of Soochow University
- Conditions
- Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Acute Myeloid Leukemia (AML)
- Interventions
- VaBU
- First posted
- 2026-05-13
- Last updated
- 2026-05-14
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Progression-Free Survival (PFS) | 1 year and 2 years post-transplantation | Progression-free survival is defined as the time from the date of transplantation to the date of disease progression, relapse, or death from any cause, whichever occurs first. Participants who are alive without progression or relapse at the last follow-up are censored. |
| Secondary | Overall Survival (OS) | 1 year and 2 years post-transplantation | Overall survival is defined as the time from the date of transplantation to the date of death from any cause. Participants who are alive at the last follow-up are censored. |
| Secondary | Cumulative Incidence of Relapse (CIR) | 1 year, 2 years | |
| Secondary | Non-relapse Mortality (NRM) | Day 100, 1 year, 2 years | |
| Secondary | GVHD-free Relapse-free Survival (GRFS) | 1 year, 2 years | |
| Secondary | Incidence of Acute GVHD | Day 100, Day 180 | |
| Secondary | Incidence of Chronic GVHD | 1 year, 2 years | |
| Secondary | CMV Reactivation Rate | 1 year | |
| Secondary | EBV Reactivation Rate | 1 year | include EBV-related post-transplant lymphoproliferative disorder (PTLD) |
| Secondary | Engraftment Rate | Day 30 |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07583888
GET https://conductscience.org/api/trials/v1/NCT07583888/registered